Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate-to Vigorous-Intensity Exercise: Results From a Survey Study

Justin C. Brown, Emily M. Ko, Kathryn H. Schmitz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The health benefits of exercise increase in dose-response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Objective: To clarify how to identify cancer survivors who should undergo a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Design: Electronic survey. Participants: Forty-seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting: Not applicable. Methods: We synthesized peer-reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre-exercise evaluation before a survivor engages in unsupervised moderate- to vigorous-intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre-exercise evaluation before they engaged in moderate- to vigorous-intensity exercise. Main Outcome Measurements: The response rate to our survey was 75% (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre-exercise evaluation for survivors before they engaged in unsupervised moderate- to vigorous-intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38%) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case-by-case basis. Conclusions: The results from this expert survey will help to identify which cancer survivors should undergo a pre-exercise evaluation before they engage in unsupervised moderate- to vigorous-intensity exercise.

Original languageEnglish (US)
Pages (from-to)113-122
Number of pages10
JournalPM and R
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Early Detection of Cancer
Survivors
Exercise
Health
Neoplasms
Comorbidity
Surveys and Questionnaires
Walking
Survival Rate
Exercise Therapy
Insurance Benefits
Cardiovascular Diseases
Medicine
Guidelines

All Science Journal Classification (ASJC) codes

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Neurology
  • Clinical Neurology

Cite this

@article{6ede698f560340abaac5f11f0bdf1a19,
title = "Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate-to Vigorous-Intensity Exercise: Results From a Survey Study",
abstract = "Background: The health benefits of exercise increase in dose-response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Objective: To clarify how to identify cancer survivors who should undergo a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Design: Electronic survey. Participants: Forty-seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting: Not applicable. Methods: We synthesized peer-reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre-exercise evaluation before a survivor engages in unsupervised moderate- to vigorous-intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre-exercise evaluation before they engaged in moderate- to vigorous-intensity exercise. Main Outcome Measurements: The response rate to our survey was 75{\%} (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre-exercise evaluation for survivors before they engaged in unsupervised moderate- to vigorous-intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38{\%}) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case-by-case basis. Conclusions: The results from this expert survey will help to identify which cancer survivors should undergo a pre-exercise evaluation before they engage in unsupervised moderate- to vigorous-intensity exercise.",
author = "Brown, {Justin C.} and Ko, {Emily M.} and Schmitz, {Kathryn H.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.pmrj.2014.09.003",
language = "English (US)",
volume = "7",
pages = "113--122",
journal = "PM and R",
issn = "1934-1482",
publisher = "Elsevier Inc.",
number = "2",

}

Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate-to Vigorous-Intensity Exercise : Results From a Survey Study. / Brown, Justin C.; Ko, Emily M.; Schmitz, Kathryn H.

In: PM and R, Vol. 7, No. 2, 01.02.2015, p. 113-122.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate-to Vigorous-Intensity Exercise

T2 - Results From a Survey Study

AU - Brown, Justin C.

AU - Ko, Emily M.

AU - Schmitz, Kathryn H.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: The health benefits of exercise increase in dose-response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Objective: To clarify how to identify cancer survivors who should undergo a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Design: Electronic survey. Participants: Forty-seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting: Not applicable. Methods: We synthesized peer-reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre-exercise evaluation before a survivor engages in unsupervised moderate- to vigorous-intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre-exercise evaluation before they engaged in moderate- to vigorous-intensity exercise. Main Outcome Measurements: The response rate to our survey was 75% (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre-exercise evaluation for survivors before they engaged in unsupervised moderate- to vigorous-intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38%) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case-by-case basis. Conclusions: The results from this expert survey will help to identify which cancer survivors should undergo a pre-exercise evaluation before they engage in unsupervised moderate- to vigorous-intensity exercise.

AB - Background: The health benefits of exercise increase in dose-response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Objective: To clarify how to identify cancer survivors who should undergo a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate- to vigorous-intensity exercise. Design: Electronic survey. Participants: Forty-seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting: Not applicable. Methods: We synthesized peer-reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre-exercise evaluation before a survivor engages in unsupervised moderate- to vigorous-intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre-exercise evaluation before they engaged in moderate- to vigorous-intensity exercise. Main Outcome Measurements: The response rate to our survey was 75% (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre-exercise evaluation for survivors before they engaged in unsupervised moderate- to vigorous-intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38%) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case-by-case basis. Conclusions: The results from this expert survey will help to identify which cancer survivors should undergo a pre-exercise evaluation before they engage in unsupervised moderate- to vigorous-intensity exercise.

UR - http://www.scopus.com/inward/record.url?scp=84923076006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923076006&partnerID=8YFLogxK

U2 - 10.1016/j.pmrj.2014.09.003

DO - 10.1016/j.pmrj.2014.09.003

M3 - Article

C2 - 25217819

AN - SCOPUS:84923076006

VL - 7

SP - 113

EP - 122

JO - PM and R

JF - PM and R

SN - 1934-1482

IS - 2

ER -